Skip to main content

SPIKEVAX (elasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial, Moderna Australia Pty Ltd, CON-984

Product name
SPIKEVAX (elasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial
Sponsor name
Moderna Australia Pty Ltd
Consent start
Consent no.
CON-984
Standard
Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines (TGO 91).
Non-compliance with standard
The carton and vial labels are supplied with 'International Labels' which do not comply with Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines (TGO 91)
Conditions imposed
1. The product must be supplied with the labels that were considered and agreed to as  part of the evaluation under section 9D(3) of the Therapeutic Goods Act 1989, being a) The 'International Labels', vial and carton labels, for drug product manufactured at Catalent Indiana LLC, referred to in submission  as follows i. Vial label for the 0.1 mg/mL suspension for injection vial ii. Carton label for the 0.1 mg/mL suspension for injection vial
Therapeutic product type
Prescription medicines

Help us improve the Therapeutic Goods Administration site